The purpose of this study is to determine whether the response to treatment for extensive
chronic Graft versus Host Disease (cGvHD)is improved with the addition of myfortic alongside
cyclosporine A and prednisone, compared to the reference treatment of cyclosporine A and
prednisone alone.
Phase:
Phase 3
Details
Lead Sponsor:
European Group for Blood and Marrow Transplantation European Society for Blood and Marrow Transplantation